Lv7
3890 积分 2021-02-08 加入
Retreatment with First-Generation Selective RET Inhibitors in RET-Rearranged NSCLC Pretreated with Selpercatinib or Pralsetinib - Results from the RET-MAP Registry
5小时前
待确认
Navigating the Evolving Landscape of EGFR -Mutated NSCLC
1个月前
已完结
Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic Leukemia
4个月前
已完结
Precision Oncology: 2025 in Review
4个月前
已完结
Stress Promotes Lung Metastasis in Breast Cancer by Altering Neutrophil Differentiation
5个月前
已完结
Rethinking Survival Metrics in EGFR-Mutated NSCLC: Insights from RMST Analysis of FLAURA2 and MARIPOSA
5个月前
已关闭
How to Communicate Medical Numbers
6个月前
已完结
The Long Ride Home
6个月前
已完结
Aryl hydrocarbon receptor ligands drive pancreatic cancer initiation and progression through pro-tumorigenic T cell polarization
7个月前
已完结
Osimertinib-induced DNA resistance mutations in cerebrospinal fluid of EGFR mutated NSCLC patients developing leptomeningeal metastases: ORA-LM study
8个月前
已完结
皖公网安备34019202002308
